Cargando…
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
Hepatocellular carcinoma (HCC) is the most common liver tumor and among the deadliest cancers worldwide. Advanced HCC overall survival is meager and has not improved over the last decade despite approval of several tyrosine kinase inhibitors (TKi) for first and second-line treatments. The recent app...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012774/ https://www.ncbi.nlm.nih.gov/pubmed/33815418 http://dx.doi.org/10.3389/fimmu.2021.655697 |